National_Coverage_Determinations_Manual / BLOOD

Why This Topic Matters

Coverage determinations affect whether services and related costs are payable under Medicare and how providers document, bill, and support care involving blood-derived wound treatments. Understanding the policy helps reduce billing errors and supports compliant claims handling for affected therapies and clinical trial settings.

Article Sections

1. General

   Introduces the blood-derived products discussed in the policy and provides background on the therapies and clinical context addressed by CMS.

2. Nationally Covered Indications

   Identifies the coverage status section for indications addressed in the determination.

3. Nationally Noncovered Indications

   Summarizes the categories of blood-derived wound treatments addressed as nationally noncovered under the determination.

4. Other

   Covers additional policy notes, including local discretion and clinical-trial-related treatment of routine costs.